Arcede Pharma
  • Home
  • R and D
  • Investors
    • Investerare (SV)
  • About us
  • News
    • News and presentations
    • Press releases
  • Contact
  • Search
  • Menu Menu
  • LinkedIn

BioStock Life Science Summit | Arcede Pharma | October 2023

October 30, 2023/0 Comments/in News/by malin@bergholm.info
Read more
https://arcedepharma.com/wp-content/uploads/2023/10/Vd_Mia.png 549 525 malin@bergholm.info https://arcedepharma.com/wp-content/uploads/2022/05/Arcede-logo_450-px-300x115.png malin@bergholm.info2023-10-30 14:22:532023-10-30 14:44:56BioStock Life Science Summit | Arcede Pharma | October 2023

Recent Posts

  • Arcede om vd-bytet och förberedelserna inför fas I
  • Investerarpresentation inför lösen av teckningsoptioner
  • Arcede Pharma förbereder för fas I med lösen i TO1
  • Arcede Pharma – Stora Aktiedagen Stockholm 28 november 2023
  • BioStock Life Science Summit | Arcede Pharma | October 2023

Recent Comments

    Archives

    • January 2024
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • June 2023
    • March 2023
    • January 2023
    • November 2022
    • October 2022
    • September 2022
    • June 2022

    Categories

    • News
    • Pressreleases

    In short

    Arcede Pharma (publ) primarily develops drug candidates with the goal of launching drugs to treat chronic obstructive pulmonary disease (COPD) and severe asthma.

    CONTACT

    Arcede Pharma AB

    Visiting Address:
    Medicon Village, Scheeletorget 1, Lund, Sweden

    Postal Address:
    Medicon Village SE-223 81 Lund, Sweden

    Latest News

    • Arcede om vd-bytet och förberedelserna inför fas IJanuary 15, 2024 - 7:53 am
    • Investerarpresentation inför lösen av teckningsoptionerJanuary 12, 2024 - 8:52 am
    Scroll to top